Financhill
Back

Traws Pharma 10K Form

Buy
53

TRAW
Traws Pharma

Last Price:
$1.71
Seasonality Move:
-15.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRAW News And Ratings

See the #1 stock for the next 7 days that we like better than TRAW

TRAW Financial Statistics

Sales & Book Value

Annual Sales: $226K
Cash Flow: $-5.4M
Price / Cash Flow: 0
Annual Sales: $1.18
Price / Book: 1.6

Profitability

EPS (TTM): -106.02870
Net Income (TTM): $-140.1M
Gross Margin: --
Return on Equity: -124.39%
Return on Assets: -779.62%

Traws Pharma Earnings Forecast

Key Traws Pharma Financial Ratios

  • The Research & Development expenses have been 5,684.51% of Revenue.
  • The Net Earning history of TRAW is -73,682.74% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 10 years.

Traws Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TRAW
Website: trawspharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.81
Quick Ratio: 1.69

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TRAW Technical Analysis vs Fundamental Analysis

Buy
53
Traws Pharma (TRAW) is a Buy

Is Traws Pharma a Buy or a Sell?

  • Traws Pharma stock is rated a Buy
    The current Traws Pharma [TRAW] share price is $1.65. The Score for TRAW is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.